Real-World Study on CDK4/6 Inhibitors Combined With Endocrine Therapy and Subsequent Treatment in HR+/HER2- MBC.

Clinical trial NCT06033287 · RECRUITING

Trial details

NCT number: NCT06033287
Sponsor: Hunan Cancer Hospital
Status: RECRUITING
Study type: OBSERVATIONAL

Breast Cancer Endocrine Therapy CDK4/6 Inhibitors Subsequent Treatment

Start date: 2023-01-01
Primary completion: 2025-12-30
Enrollment: 300

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.